teclistamab
genmab,janssen
['multiple myeloma', 'teclistamab', 'mmsm']
amrita y. krishnan, md, spoke about the use of teclistamab vs real-world data in patients with relapsed/refractory multiple myeloma. #mmsm #asco22 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.